相关实验视频
Updated: Jul 17, 2025

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
21.9K
在急性缺血性中风中,特内克与阿尔特相对应:对III期随机试验的元分析
Yunyun Xiong1,2,3, Liyuan Wang1, Guangshuo Li1
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Stroke and vascular neurology
|August 28, 2023
概括
甲 (TNK) 在急性缺血性中风 (AIS) 中与甲一样有效和安全. 这项研究证实TNK是AIS患者可行的替代治疗选择.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 最近的试验表明,基酶 (TNK) 与高酶无差.
- 治疗急性缺血性中风 (AIS) 的疗效和安全性至关重要.
研究的目的:
- 为了比较TNK与ALTEPLASE在AIS患者中的疗效和安全性.
- 为了确定TNK是否是一个适合的替代品Alteplase.
主要方法:
- 对III期临床试验进行系统的文献搜索和元分析.
- 主要结局:卓越的功能结局 (修改的兰金尺度0-1在90天).
- 安全结果:有症状的脑内出血和90天死亡.
主要成果:
- 在三项试验中对4094名患者的元分析显示,TNK (53.0%) 对于优异的功能性结果而言,不低于阿尔特 (50.5%).
- TNK并没有增加症状性脑内出血或死亡的风险.
- 敏感性分析证实了结果,达到非劣势值.
结论:
- 在AIS患者的优异功能结果方面,丁烯基与高相比并非劣.
- 与alteplase相比,TNK不会引发安全问题.
- TNK为急性缺血性中风提供了一种有价值的替代治疗方法.
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Acute Coronary Syndrome III: Diagnostic Studies
10
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Acute Coronary Syndrome I: Introduction
30
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30

